Study of Mycobacterial Infections
NCT00018044 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-05-12
Summary
This study will examine the symptoms, course of disease and treatment of non-tuberculous mycobacterial (NTM) infections, as well as the genetics involved in these infections. Patients with NTM have recurrent lung infections and sometimes infections of the skin and other organs as well. They may also have curvature of the spine, barrel chest, and heart valve weakness. The study will compare the features of NTM with those of Job syndrome and cystic fibrosis, other diseases involving recurrent infections of the lungs and possibly other organs.
Patients with diagnosed or suspected non-tuberculous mycobacterial infection, cystic fibrosis or Job syndrome may be eligible for this study. All participants will have a medical and family history, blood and urine tests, imaging studies that may include X-rays, computed tomography (CT) or magnetic resonance imaging (MRI) scans, and DNA and other genetic studies. In addition, all patients with Job syndrome and cystic fibrosis, and patients with NTM who have lung disease undergo the following procedures:
* Scoliosis survey X-rays of the spine to look for curvature or other abnormalities of the spinal column
* Echocardiography imaging test that uses sound waves to examine the heart chambers and valves
* Electrocardiogram measurement of the electrical activity of the heart
* Pulmonary function tests breathing tests to measure how much air the patient can move into and out of the lungs
* Body measurements measurements of height, weight, arm span, finger length, etc.
* Joint function assessment of joint mobility using different maneuvers to test flexibility of joints and ligaments
* Examination of physical features that might be associated with NTM, such as high arched palate of the mouth, flat feet, or certain skin features
* Dermatology (skin) examination for reactive skin conditions or other skin problems and possibly a skin biopsy (surgical removal of a small skin tissue sample for microscopic examination)
* Interview with genetics specialist
These tests may require several days to complete. Patients with NTM will also be examined by a cystic fibrosis specialist and may have a sweat test. In addition, NTM patients will be asked to return to NIH every year for 5 years for follow-up tests, if medically indicated, including CT of the chest, scoliosis survey and examination by other specialists.
...
Conditions
- Mycobacterium Infections
Interventions
- DRUG
-
Clofazimine
Sponsors & Collaborators
-
Children's National Research Institute
collaborator OTHER -
University of Miami
collaborator OTHER -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Steven M Holland, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-01-01
Countries
- United States
Study Locations
More Related Trials
-
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
NCT06226662 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Genetic Susceptibility Factors for Candidemia.
NCT02841501 ·Status: COMPLETED
-
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
NCT00104299 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Factors Regulating Mast Cell Proliferation
NCT00044122 ·Status: RECRUITING
-
A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis
NCT07298928 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CHronic Nonbacterial Osteomyelitis International Registry
NCT04725422 ·Status: RECRUITING
-
MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis
NCT04244916 ·Status: TERMINATED
-
MISC COVID-19 Study in Pediatric Population
NCT04844242 ·Status: RECRUITING
-
Mycophenolate for Pulmonary Sarcoidosis
NCT00262132 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
NCT01717170 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
NCT00647166 ·Status: COMPLETED ·Phase: PHASE3
-
Characteristics of Mast Cells in Mastocytosis
NCT00001356 ·Status: COMPLETED
-
Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers
NCT05353179 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
NCT00027443 ·Status: COMPLETED ·Phase: NA
-
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 ·Status: COMPLETED
-
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
NCT07249632 ·Status: RECRUITING ·Phase: PHASE3
-
Colchicine for Patients With Chagas´ Disease( B1 Stage)
NCT03704181 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
NCT04944524 ·Status: UNKNOWN ·Phase: PHASE4
-
CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
NCT00400075 ·Status: UNKNOWN ·Phase: PHASE4
-
Immun Response in Children With MIS-C
NCT05052424 ·Status: UNKNOWN
-
Effect of Tofacitinib in Treating ANCA-associated Vasculitis
NCT04973033 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Natural History of Hypereosinophilia and Hypereosinophilic Syndromes
NCT04018118 ·Status: RECRUITING
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Development of a Novel Human In Vitro Sarcoidosis Model
NCT01857401 ·Status: COMPLETED